Intratumoral CXCL12 Gradients Contextualize Tumor Cell Invasion, Migration and Immune Suppression in Breast Cancer
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The CXCL12/CXCR4 pathway guides cancer cells to metastasis doorways and creates immune-suppressive zones. This pathway hinders CD8+ T cell function near these doorways, impacting cancer spread and immunity.
Area Of Science
- Oncology
- Immunology
- Cell Biology
Background
- The CXCL12/CXCR4 pathway is implicated in tumor metastasis and immune suppression.
- Limited understanding exists regarding the spatiotemporal regulation of this pathway in the tumor microenvironment.
- Cancer cell intravasation doorways, termed Tumor Microenvironment of Metastasis (TMEM) doorways, are critical for metastasis initiation.
Purpose Of The Study
- To investigate the spatiotemporal regulation of the CXCL12/CXCR4 pathway in breast cancer metastasis.
- To elucidate the role of CXCL12 gradients in facilitating cancer cell intravasation.
- To examine the impact of the CXCL12-rich microenvironment on CD8+ T cell function and distribution.
Main Methods
- Analysis of CXCL12 gradients around TMEM doorways.
- Assessment of CXCR4-expressing tumor cell chemotaxis towards TMEM doorways.
- Evaluation of CD8+ T cell effector functions and distribution in CXCL12-rich regions.
Main Results
- CXCL12 forms a gradient around TMEM doorways, attracting prometastatic tumor cells.
- The CXCL12-rich microenvironment creates immunosuppressive niches, reducing CD8+ T cell efficacy.
- CXCL12/CXCR4 pathway influences CD8+ T cell distribution, moving them away from TMEM doorways.
Conclusions
- CXCL12/CXCR4 pathway orchestrates tumor cell metastasis and immune evasion.
- The pathway contributes to the initial steps of the metastatic cascade and establishes an immunological sanctuary.
- Findings offer insights for therapeutic strategies targeting breast cancer metastasis and enhancing anti-tumor immunity.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...